{"id":"NCT00432237","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016)","officialTitle":"A Phase III, Multicenter, Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of Oral MK0974 in the Acute Treatment of Migraine With or Without Aura","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03","primaryCompletion":"2007-12","completion":"2007-12","firstPosted":"2007-02-07","resultsPosted":"2010-12-06","lastUpdate":"2015-07-03"},"enrollment":1703,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine"],"interventions":[{"type":"DRUG","name":"MK0974 50 mg","otherNames":["MK0974"]},{"type":"DRUG","name":"MK0974 150 mg","otherNames":["MK0974"]},{"type":"DRUG","name":"MK0974 300 mg","otherNames":["MK0974"]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]}],"arms":[{"label":"MK0974 50 mg","type":"EXPERIMENTAL"},{"label":"MK0974 150 mg","type":"EXPERIMENTAL"},{"label":"MK0974 300 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to investigate the efficacy and safety of MK0974 compared to a placebo for acute migraine.","primaryOutcome":{"measure":"Number of Patients Reporting Pain Freedom at 2 Hours Postdose","timeFrame":"2 hours post dose","effectByArm":[{"arm":"MK0974 50 mg","deltaMin":29,"sd":null},{"arm":"MK0974 150 mg","deltaMin":88,"sd":null},{"arm":"MK0974 300 mg","deltaMin":88,"sd":null},{"arm":"Placebo","deltaMin":39,"sd":null}],"pValues":[{"comp":"OG001 vs OG003","p":"<0.001"},{"comp":"OG002 vs OG003","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["19770473"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":177},"commonTop":["Nausea","Dry Mouth","Fatigue","Dizziness","Somnolence"]}}